Vaccine News and Research

Latest Vaccine News and Research

Study on mpox epidemiology in New York during summer 2022

Researchers presented a summary of their experience of identifying, managing, and vaccinating monkeypox (MPX) virus (MPXV)-infected individuals in New York during the summer season of 2022.

30 Nov 2022

Australian researchers unearth a new form of antimicrobial resistance

Australian researchers have uncovered a new form of antimicrobial resistance (AMR) – undetectable using traditional laboratory testing methods – in a discovery set to challenge existing efforts to monitor and tackle one of the world's greatest health threats.

30 Nov 2022

Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants

Researchers systematically reviewed SARS-CoV-2 Omicron BQ.1.1 neutralization data from individual patient samples.

30 Nov 2022

Zika-exposed children may show differences in cognitive development, mood and mobility

Children who are exposed to the Zika virus while in the womb, but who are not subsequently diagnosed with Zika-related birth defects and congenital Zika syndrome (CZS), may still display differences in some aspects of cognitive development, mood and mobility compared to unexposed children, reports a study published in Pediatric Research.

30 Nov 2022

Fragment crystallizable receptor-effector functions as a key correlate for pan-sarbecovirus vaccine development

Researchers elucidated pan-sarbecovirus immune protection mechanisms by utilizing a Venezuelan equine encephalitis virus-vectored vaccine panel that covered bat strains to human strains.

30 Nov 2022

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

A recent study identified neutralizing antibodies against conserved SARS-CoV-2 epitopes.

30 Nov 2022

The antibody resistance profile and viral receptor binding affinity of SARS-CoV-2 Omicron BQ.1, BQ.1.1, XBB, and XBB.1 subvariants

Researchers investigated the neutralizing antibody titers against the newly emergent BQ.1, BQ.1.1, XBB, and XBB.1 SARS-CoV-2 Omicron subvariants using sera from individuals with primary and booster COVID-19 vaccinations and previous SARS-CoV-2 infections.

30 Nov 2022

Miracles Start in the Lab: The quest to find a vaccine to cure AIDS

To commemorate World AIDS Day, News Medical spoke to Dr. Larry Corey, an internationally renowned expert in virology, immunology, and vaccine development, and the former president and director of Fred Hutch, about his work within the field of HIV/AIDS research and vaccine development.

30 Nov 2022

Monkeypox renamed "mpox" in an effort to combat stigma

WHO announces that the monkeypox virus will now be referred to as “mpox” in an effort to reduce the stigmatization of this condition.

29 Nov 2022

COVID-19 pandemic fatigue in Hong Kong

Pandemic fatigue impeded the mitigation of COVID-19 in Hong Kong.

29 Nov 2022

Engineered proteins can be delivered as a nasal spray to protect against and treat COVID-19

COVID-19 has had a lasting global health impact that continues to challenge the health care system. As the coronavirus continues to mutate, the current COVID-19 prevention strategies are plagued with supply chain disruptions, high vaccine manufacturing costs and inconvenient vaccine administration methods.

29 Nov 2022

COVID-19 boosters and updated vaccines are more important for older adults, study suggests

The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.

29 Nov 2022

New biosensing platform detects SARS-CoV-2 antibodies in five minutes

Rapid, cheap and accurate tests continue to be essential for epidemiological surveillance and for health services to monitor and contain the spread of SARS-CoV-2. Brazilian scientists have contributed to endeavors in this field by developing an electrochemical immunosensor that detects antibodies against the virus.

29 Nov 2022

Impact of an individually tailored educational application on vaccine attitudes of pregnant women and mothers

Researchers evaluated the impact of MomsTalkShots, a personalized application, on maternal attitudes toward vaccinations.

29 Nov 2022

The impact of Pfizer‐BioNTech’s BNT162b2 mRNA vaccine booster on the maximum oxygen uptake capacity among recreational endurance athletes

Researchers evaluated the impact of Pfizer‐BioNTech’s BNT162b2 mRNA vaccine booster on the maximum oxygen uptake capacity (VO2max) among recreational endurance athletes.

29 Nov 2022

Small UK study investigates the effectiveness of a single MVA-BN dose against mpox disease

Researchers estimated the single-dose MVA-BN vaccine effectiveness against symptomatic mpox among high-risk gay, bisexual and other men who have sex with men in England.

29 Nov 2022

Small CDC study looks at SARS-CoV-2 viral shedding in vaccinated and unvaccinated

A new Centers for Disease Control and Prevention (CDC) study published in the Vaccine journal aimed to analyze the viral shedding and conversion timeline of SARS-CoV-2 infected people from exposure to infection and onset of symptoms during a period of Delta outbreak in a federal prison in Texas.

28 Nov 2022

Vaccine News and Research

Latest Vaccine News and Research

Study on mpox epidemiology in New York during summer 2022

Australian researchers unearth a new form of antimicrobial resistance

Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants

Zika-exposed children may show differences in cognitive development, mood and mobility

Fragment crystallizable receptor-effector functions as a key correlate for pan-sarbecovirus vaccine development

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

The antibody resistance profile and viral receptor binding affinity of SARS-CoV-2 Omicron BQ.1, BQ.1.1, XBB, and XBB.1 subvariants

Miracles Start in the Lab: The quest to find a vaccine to cure AIDS

Monkeypox renamed "mpox" in an effort to combat stigma

COVID-19 pandemic fatigue in Hong Kong

Engineered proteins can be delivered as a nasal spray to protect against and treat COVID-19

COVID-19 boosters and updated vaccines are more important for older adults, study suggests

New biosensing platform detects SARS-CoV-2 antibodies in five minutes

Impact of an individually tailored educational application on vaccine attitudes of pregnant women and mothers

The impact of Pfizer‐BioNTech’s BNT162b2 mRNA vaccine booster on the maximum oxygen uptake capacity among recreational endurance athletes

Small UK study investigates the effectiveness of a single MVA-BN dose against mpox disease

Small CDC study looks at SARS-CoV-2 viral shedding in vaccinated and unvaccinated

An analysis of COVID-19's dynamics, its impact on various age groups, anti-vaxxers and re-infection

Large COVID vaccination study found that thrombosis and thrombocytopenia are very rare complications

Could mRNA vaccines triumph over other viral infections in humans and domestic animals?

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in